Souhaitez-vous accéder aux communiqués récents ?

Neil Gallagher, MD, PhD, joins with over 25 years clinical development experience, having contributed to multiple commercial therapeutics across haematology and oncologyHis appointment will strengthen...

Professor Isidro Cortés-Ciriano, an internationally recognised scientist with extensive experience in childhood cancer research, will accelerate Oxford-Harrington’s mission to translate discoveries...

Brendan Walsh brings more than 20 years of operational leadership to support George Medicines’ global commercial expansion of GMRx2 London, UK, Boston, MA, 29 June 2026 – George Medicines, a...

Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and...

Pharmaceutical executive brings 25+ years of international commercial leadership and rare disease experience Egham, UK – 18 June 2026 – Essential Pharma ("Essential" or "the Company"), a global...

COMMUNIQUÉ — 17.06.2026 Cyril Marie nommé membre du Directoire de Wendel Wendel annonce la nomination de Cyril Marie en qualité de membre du Directoire, Directeur général adjoint en charge de...

PRESS RELEASE — JUNE 17, 2026 Cyril Marie appointed to Wendel’s Executive Board Wendel announces the appointment of Cyril Marie as a member of the Executive Board and Executive Vice-President in...

DUBLIN and LONDON, 15 June 2026 -- Aerska, a biotechnology company using brain shuttle technology to develop RNA medicines for CNS diseases, today announces the appointment of Itziar Canamasas and Uli...

Oriva Therapeutics announces the appointment of seasoned biotech entrepreneur Dr Agnès Arbat as Chief Executive Officer.

amana welcomes Nikos Tsoskounoglou to lead quantitative market making and research, supporting the firm's next phase of growth.